Steroid responsive meningitis-arteritis (SRMA) in dogs is an ‘immune mediated’ or ‘auto-immune’ condition where inflammation occurs in the blood vessels in the lining of the nervous system (the meninges). Infections of the nervous system are uncommon in dogs in the UK due to vaccinations. This depends on what your vet is treating, the dose for steroid tablets like this varies greatly depending on the condition being treated. We strongly advise you contact your vet to discuss this further as they will be able to explain the dose they have recommended to you.
Despite the side-effects that may be caused by steroid use, your vet will try to ensure that these won’t occur by using the lowest dose that is effective for treating your pet’s condition. This category of steroids for dogs is prescribed for respiratory conditions. They are administered through the use of a nebulizer or an inhaler and this allows the steroids to head straight to the target area, reducing the risk of side effects. Occasional visits to your vet may be required during the course of treatment.
Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of commonly used painkillers. Corticosteroids can also be used to replace certain hormones that aren’t naturally produced by the body. A while back, I shared results on a small study that looked at the potential behavioral side effects of steroids in dogs. A more recent study was completed by Notari, Burman, and Mills that took the next step into studying the effects of steroids on dogs.
Sometimes we need to use other drugs to compliment the use of steroids, allowing us to reduce the steroid dose whilst still controlling the disease. Thankfully yes and, in the long term, most dogs will be able to live a normal life. The mainstay of treating SRMA is suppression of the immune system with drugs, particularly high doses of corticosteroids like Prednisolone, to counteract the ‘over-excitation’ of the immune system. The administration of high doses of steroids by injection, or orally, very often results in significant and rapid improvement, or resolution of the clinical signs.
Rinsing your mouth out with water after using your medication can help to prevent oral thrush. Using a device called a spacer with your medication can help to prevent many of the other problems. The American College of Veterinary Behaviorists is an organization of veterinarians who have had years of training, education and certification in animal behavior. Our programme promises to support you through every stage of your journey.
This is beneficial for skin conditions characterized by itching, such as atopic dermatitis, flea allergy, insect bites, and hot spots. The immune system normally fights infections, but in some conditions it becomes overactive and starts to attack the normal tissues of the body – this is called, ‘immune-mediated disease’. Steroids have a wide range of effects, and can be used for a broad spectrum of diseases, ranging from the minor to serious life-threatening problems.
If you have any concerns about the steroid treatment your pet has been prescribed it is always best to discuss this with your vet. If you are concerned about any potential side effects of the steroid treatment prescribed you should consult your vet for advice. Your vet will aim to minimise any side effects experienced by adjustment of the dose if needed. Sometimes if side effects are particularly problematic, additional medications may be added into the treatment plan so a lower dose of steroid could be considered.
There a few different veterinary licensed brands of prednisolone but they are all guaranteed to be the same. If you want to check that your medicines are safe to take with your medication, ask your sashaconstable Pharmacist or GP. Please take time to read the patient information leaflet that comes with your medicine. However, they’re not usually recommended unless the potential benefits outweigh the risks.
Some will need to be on the low end of the therapeutic range while others will need to be at the top end to experience therapeutic effects. This means that checking the concentrations are within the therapeutic range is not enough and consideration must be given to what effects (beneficial or undesirable) it has on the animal. There is insufficient evidence to support the use of alternative immunosuppressive agents in place of corticosteroids for the treatment of IMPA type I. Further controlled clinical trials are needed before a change to clinical practice can be considered.